Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
Title:
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium
Author:
Jacobs, Miriam T. Jain, Michael D. Gao, Feng Nastoupil, Loretta J. Spiegel, Jay Y. Lin, Yi Dahiya, Saurabh Lunning, Matthew Lekakis, Lazaros Reagan, Patrick M. Oluwole, Olalekan O. McGuirk, Joseph Deol, Abhinav Sehgal, Alison Goy, Andre Hill, Brian T. Andreadis, Charalambos Munoz, Javier Chavez, Julio C. Bennani, N. Nora Rapoport, Aaron P. Vose, Julie M. Miklos, David B. Neelapu, Sattva S. Ghobadi, Armin Locke, Frederick L.